Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022.

"Conflict of interest: Jacek Kubica: lecture fees from AstraZeneca, Bayer; Piotr Adamski: none; Jerzy R. Ładny: none; Jarosław Kaźmierczak: none; Tomasz Fabiszak: none; Krzysztof J. Filipiak: lecture fees from Adamed, AstraZeneca, Sanofi Aventis; Robert Gajda: none; Mariusz Gąsior: lecture fees from AstraZeneca; Zbigniew Gąsior: none; Robert Gil: none; Jarosław Gorący: lecture fees from Astra-Zeneca; Stefan Grajek: none; Leszek Gromadziński: none; Marcin Gruchała: none; Grzegorz Grześk: none; Piotr Hoffman: none; Miłosz J. Jaguszewski: speaking fees and travel grants from: Boheringer Ingelheim, Bayer, AstraZeneca, and Pfizer outside the submitted work; Marianna Janion: none; Piotr Jankowski: lecture fees, conference and scientific grants from Amgen, Boehringer Ingelheim, KRKA, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Teva, Zentiva; Zbigniew Kalarus: none; Jarosław D. Kasprzak: lecture fees from Aflofarm, Polpharma, AstraZeneca, research grants from Aflofarm; Andrzej Kleinrok: none; Wacław Kochman: none; Aldona Kubica: none; Wiktor Kuliczkowski: none; Jacek Legutko: lecture fees from AstraZeneca, Berlin-Chemie Menarini, Gedeon Richter; Maciej Lesiak: lecture fees from AstraZeneca, Gedeon Richter; Klaudiusz Nadolny: none; Eliano P. Navarese: none; Piotr Niezgoda: none; Małgorzata Ostrowska: none; Przemysław Paciorek: none; Jolanta Siller-Matula: none; Łukasz Szarpak: none; Dariusz Timler: none; Adam Witkowski: lecture fees from AstraZeneca, Bayer, Boehringer Ingelheim, Pfizer; Wojciech Wojakowski: lecture fees from Astra-Zeneca, Pfizer, Boehringer Ingelheim; Andrzej Wysokiński: none; Marzenna Zielińska: none."